Y06137 T13363
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Y06137 is a potent and selective inhibitor of BET, and used for treatment of castration-resistant prostate cancer (CRPC). Y06137 binds to the BRD4(1) bromodomain with a Kd of 81 nM.
CAS nr:
2226534-49-0
Purity:
98%
Molecular Weight:
444,57
SMILES:
CC1=NOC(C1=C2)=CC=C2C3=NC(C=C4)=C(N3CC5CCCCC5)C=C4N6CCOC[C@@H]6C
Formula:
C27H32N4O2
Pathway:
Cytoskeletal Signaling,Chromatin/Epigenetic,Chromatin/Epigenetic
Target:
PKC,PKC,Epigenetic Reader Domain
